BURR, RANDON MICHAEL,AMBATI, BALAMURALI K.,MOLOKHIA, SARAH A.
申请号：
CA3087622
公开号：
CA3087622A1
申请日:
2019.01.07
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
